Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ETOPOPHOS: 17 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
17
Total FAERS Reports
3 (17.6%)
Deaths Reported
3
Hospitalizations
17
As Primary/Secondary Suspect
8
Life-Threatening
1
Disabilities

First Report: 2007 · Latest Report: 20140317

What Are the Most Common ETOPOPHOS Side Effects?

#1 Most Reported
Hepatotoxicity
7 reports (41.2%)
#2 Most Reported
Dilatation intrahepatic duct acquired
7 reports (41.2%)
#3 Most Reported
Venoocclusive liver disease
6 reports (35.3%)

All ETOPOPHOS Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Dilatation intrahepatic duct acquired 7 41.2% 0 0
Hepatotoxicity 7 41.2% 0 0
Venoocclusive liver disease 6 35.3% 0 0

Who Reports ETOPOPHOS Side Effects? Age & Gender Data

Average age: 29.9 years. Most reports from: GB. View detailed demographics →

Is ETOPOPHOS Getting Safer? Reports by Year

YearReportsDeathsHosp.
2007 7 0 0
2010 1 0 0
2011 1 1 0
2012 1 0 1
2013 3 0 1
2014 2 0 1

View full timeline →

Official FDA Label for ETOPOPHOS

Official prescribing information from the FDA-approved drug label.